Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Healthtrust
Chubb
Cerilliant
Merck
Harvard Business School
Cantor Fitzgerald
Covington

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074225

« Back to Dashboard

NDA 074225 describes BUMETANIDE, which is a drug marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Ivax Sub Teva Pharms, Sandoz, and Upsher-smith Labs, and is included in nine NDAs. It is available from twenty suppliers. Additional details are available on the BUMETANIDE profile page.

The generic ingredient in BUMETANIDE is bumetanide. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 074225
Tradename:BUMETANIDE
Applicant:Ivax Sub Teva Pharms
Ingredient:bumetanide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074225
Medical Subject Heading (MeSH) Categories for 074225
Suppliers and Packaging for NDA: 074225
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUMETANIDE bumetanide TABLET;ORAL 074225 ANDA Teva Pharmaceuticals USA Inc 0093-4232 N 0093-4232-01
BUMETANIDE bumetanide TABLET;ORAL 074225 ANDA Teva Pharmaceuticals USA Inc 0093-4233 N 0093-4233-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Apr 24, 1995TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Apr 24, 1995TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Apr 24, 1995TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Colorcon
UBS
Fish and Richardson
US Department of Justice
Chinese Patent Office
Queensland Health
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.